Paying users zone. Data is covered by .

  • Get to Biogen Inc. for $13.99, or

  • get to whole website for at least 3 months from $49.99.

  2. Biogen Inc.
  3. Income Statement
 

$13.99

Biogen Inc. (BIIB)

Income Statement

Difficulty: Beginner

The income statement presents information on the financial results of a company's business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Biogen Inc., Consolidated Income Statement

USD $ in thousands

 
12 months ended Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Product, net
Revenues from anti-CD20 therapeutic programs
Other
Revenues
Cost of sales, excluding amortization of acquired intangible assets
Gross profit
Research and development
Selling, general and administrative
Amortization of acquired intangible assets
Acquired in-process research and development
Collaboration profit sharing
Gain (loss) on fair value remeasurement of contingent consideration
Restructuring charges
TECFIDERA litigation settlement charges
Gain on sale of rights
Income from operations
Interest income
Interest expense
Impairments on investments
Gain (loss) on investments, net
Foreign exchange gains (losses), net
Other, net
Other income (expense), net
Income before income tax expense and equity in loss of investee, net of tax
Income tax expense
Equity in loss of investee, net of tax
Net income
Net (income) loss attributable to noncontrolling interests, net of tax
Net income attributable to Biogen Inc.
Source: Biogen Inc., Annual Reports
Item Description The company
Revenues Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Biogen Inc.'s revenues increased from 2015 to 2016 and from 2016 to 2017.
Income from operations The net result for the period of deducting operating expenses from operating revenues. Biogen Inc.'s income from operations increased from 2015 to 2016 and from 2016 to 2017.
Income before income tax expense and equity in loss of investee, net of tax Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest. Biogen Inc.'s income before income tax expense and equity in loss of investee, net of tax increased from 2015 to 2016 and from 2016 to 2017.
Net income The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Biogen Inc.'s net income increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Net income attributable to Biogen Inc. The portion of consolidated profit or loss for the period, net of income taxes, which is attributable to the parent. If the entity does not present consolidated financial statements, the amount of profit or loss for the period, net of income taxes. Biogen Inc.'s net income attributable to Biogen Inc. increased from 2015 to 2016 but then declined significantly from 2016 to 2017.

Top

Stock Analysis on Net